About RetiSpec
RetiSpec is a company based in Tel Aviv (Israel) founded in 2015. RetiSpec has raised $10 million across 3 funding rounds from investors including Lilly, Gentex and University of Minnesota. RetiSpec offers products and services including Hyperspectral Imaging Technology and Retinal Scanner. RetiSpec operates in a competitive market with competitors including Tobii Dynavox, Inscopix, Neurotrack, Brainomix and Artiria, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Retispec Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Jul 26, 2024
-
Investors
Lilly
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RetiSpec
RetiSpec offers a comprehensive portfolio of products and services, including Hyperspectral Imaging Technology and Retinal Scanner.
AI-based system for detecting Alzheimer's via retinal scans.
Non-invasive tool for early identification of brain amyloid build-up.
People of RetiSpec
Unlock access to complete
Unlock access to complete
Funding Insights of RetiSpec
RetiSpec has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RetiSpec
RetiSpec has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Gentex and University of Minnesota.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused venture capital is provided by iGan Partners.
|
Locked | Locked | Locked | |
|
Brain research and care innovation is driven in Ontario.
|
Locked | Locked | Locked | |
|
Innovation in aging and brain health is driven by CABHI.
|
Locked | Locked | Locked |
Investor details for RetiSpec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RetiSpec
Investment portfolio details for RetiSpec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RetiSpec
Detailed financials for RetiSpec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Retispec Comparisons
Peer comparison for RetiSpec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RetiSpec
RetiSpec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Inscopix, Neurotrack, Brainomix and Artiria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| Locked | Locked | Locked |
Neurological disorders are diagnosed using eye-tracking assessment tools.
|
|
| Locked | Locked | Locked |
AI-powered imaging biomarkers are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
Detailed competitors of RetiSpec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Retispec
Complete news archive for RetiSpec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RetiSpec
RetiSpec was founded in 2015 and raised its 1st funding round 2 years after it was founded.
RetiSpec is headquartered in Tel Aviv, Israel.
RetiSpec is a funded company, having raised a total of $10M across 3 funding rounds to date.
RetiSpec was an early stage medical device startup developing a non-invasive eye scanner for early detection of Alzheimers Disease. The company was selected as the finalists at the MassChallenge Boston accelerator had won 1st place at the JNF Lions-Den competition in Toronto at the 2016 Partners Connected Health and AARP startup competition in Boston. As of Jan 2017, the company hasnt disclosed its product development details.
RetiSpec's top competitors include NovaSight, CND Life Sciences and NeuroKaire.
RetiSpec offers Hyperspectral Imaging Technology and Retinal Scanner.
RetiSpec has 9 investors. Key investors include Lilly, Gentex, University of Minnesota, Alzheimer's Drug Discovery, and iGan Partners.